Nano-X Imaging Ltd. (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp. to support the deployment of the Nanox.ARC across New England. The partnership is set to expand the reach of the FDA-cleared, multisource 3D digital tomosynthesis system in outpatient and community-based clinical settings, marking a significant step in the company's strategy to broaden access to advanced imaging technology.
Under the agreement, Associated X-Ray Imaging will market, distribute, and support the Nanox.ARC, leveraging its established regional customer relationships and service infrastructure. This collaboration is intended to increase the availability of the Nanox.ARC in targeted markets throughout New England, potentially enabling more healthcare providers to offer advanced diagnostic imaging to their patients. The Nanox.ARC is designed to be a cost-effective and scalable imaging solution, which could make it particularly appealing for smaller practices and community health centers that may have previously faced financial or logistical barriers to adopting such technology.
The expansion of Nanox's U.S. channel partner network is part of a broader effort to drive the world's transition to preventive healthcare. By integrating affordable imaging hardware with AI-based solutions, cloud-based software, and remote radiology services, Nanox aims to lower barriers to adoption and improve utilization of medical imaging. The company's ecosystem includes the Nanox.ARC, Nanox.AI algorithms that augment CT imaging interpretation, Nanox.CLOUD for data management, and Nanox.MARKETPLACE along with USARAD Holdings for teleradiology services. Additionally, Nanox Health IT provides RIS, PACS, and other workflow solutions to streamline care delivery.
The importance of this announcement lies in its potential to increase early detection of chronic diseases in underserved regions. By expanding distribution through regional partners like Associated X-Ray Imaging, Nanox is positioning itself to make advanced imaging more accessible outside of traditional hospital settings. This move aligns with the company's vision to enhance the efficiency of routine imaging workflows and support earlier diagnosis, which could lead to better patient outcomes and reduced healthcare costs in the long term.
Nanox's approach combines cutting-edge technology with a clinically driven focus, aiming to integrate imaging, AI, and health IT into a seamless solution from scan to interpretation. The company's recent efforts to expand its distribution network reflect a strategic push to penetrate new markets and build a robust presence in the U.S. healthcare landscape. For more information on Nanox and its subsidiaries, visit the company's newsroom at https://ibn.fm/NNOX.
While forward-looking statements in the announcement suggest optimistic growth prospects, they are subject to risks and uncertainties that could cause actual results to differ. Investors are encouraged to review the risk factors detailed in the company's filings with the SEC. As Nanox continues to expand its distribution agreements, the healthcare industry will be watching to see how these partnerships translate into increased adoption of the Nanox.ARC and improved access to preventive imaging services.
